Study examines BIAS and IBCG criteria for predicting high-grade recurrence in low-grade NMIBC on active surveillance

Retrospective · UroToday · 2026-10-07. Number 5 in the UrologyWatch Top 5 for October 11, 2026.

A study evaluated the BIAS and IBCG risk criteria for predicting recurrence with high-grade disease among patients with low-grade NMIBC eligible for active surveillance. Specific design details (e.g., retrospective or prospective) and outcome data are not specified in the available source text.

Why it matters: May help inform which low-grade NMIBC patients are better suited to active surveillance versus closer monitoring, pending full study details.

Source: UroToday · PubMed 42834313 · DOI 10.1007/s11255-026-05411-x

The full October 11, 2026 edition · Today's urology news